科迪塞宾通过激活SLC7A11/GPX4通路来改善糖尿病病损伤
Bing Wu1, Jing Wang1, Xiaohui Yan1
1Department of Nephrology, Shaanxi Provincial People's Hospital, Xi'an, Shaanxi, China.
Journal of diabetes investigation
|March 22, 2025
概括
科迪塞宾 (CRD) 通过减少细胞亡,炎症和铁亡,有效治疗糖尿病病 (DN). 这种化合物激活SLC7A11/GPX4通路,为DN提供了潜在的治疗策略.
科学领域:
- 生物化学 生物化学
- 细胞生物学 细胞生物学
- 腎臟病學 (nephrology) 是一種醫學專業.
背景情况:
- 科迪塞宾 (CRD) 显示出减轻糖尿病引起的并发症,特别是糖尿病病 (DN) 的潜力.
- 了解CRD影响DN进展的精确机制对于治疗开发至关重要.
研究的目的:
- 调查Cordicepin (CRD) 对糖尿病病 (DN) 进展的特定影响.
- 阐明潜在的分子机制,重点关注亡,炎症和 podocytes 中的 ferroptosis.
主要方法:
- 在体外研究中,使用高葡萄糖 (HG) 诱导的小鼠足细胞细胞系 (MPC5) 进行功能分析.
- 检测包括细胞计数套件-8,5-乙烯基-2'-脱氧氨,流动细胞计量,ELISA,以及Fe2+,谷氨,活性氧物种和malonaldehyde的测量.
- 在体内研究涉及STZ诱导的糖尿病小鼠,以评估脏结构和炎症.
主要成果:
- 治疗CRD显著抑制了HG诱导的亡,炎症和细胞中的铁亡.
- 在受HG治疗的小细胞中,CRD提高了SLC7A11和GPX4的表达.
- 在糖尿病小鼠中,CRD改善了损伤和炎症,与调节的SLC7A11/GPX4表达相关.
结论:
- 科尔迪塞宾 (CRD) 通过抑制亡,炎症和铁亡,对高葡萄糖诱导的细胞损伤产生保护作用.
- 实验室和体内CRD的治疗作用通过激活SLC7A11/GPX4通路进行调解.
- CRD代表了糖尿病病 (DN) 的有前途的治疗药物.
相关概念视频
Antihypertensive Drugs: Potassium-Sparing Diuretics
426
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
426
Renal Corpuscle
1.4K
The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
1.4K
Heart Failure Drugs: Diuretics
312
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
312
Antihypertensive Drugs: Action of Diuretics
597
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
597
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
356
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
356
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
436
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
436


